TAK-700 in Localized Prostate Cancer Clinical Trials

Dr. Howard Sandler from Cedars-Sinai Medical Center discusses the TAK-700 in Localized Prostate Cancer Clinical Trials

Howard M. Sandler, MD, MS, from Cedars-Sinai Medical Center, discusses the examination of hormonal and radiation therapy used in combination for localized prostate cancer. A new agent named TAK-700 is being examined in multiple studies for various types of prostate cancer.

View more videos of Howard M. Sandler, MD.